Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010)
Stryker (SYK) reported Curent Deferred Tax Liability of $26.9 million for Q4 2010, up 11.62% year-over-year from $24.1 million in Q4 2009, and up 11.62% quarter-over-quarter from $24.1 million in Q4 2009.
Stryker (SYK) Curent Deferred Tax Liability (2009 - 2010) Analysis & Trends
Stryker (SYK) has 2 years of Curent Deferred Tax Liability data on file, last reported at $26.9 million in Q4 2010.
- Curent Deferred Tax Liability for Q4 2010 came in at $26.9 million, up 11.62% year-over-year; the trailing twelve-month figure through Dec 2010 was $26.9 million (up 11.62% YoY), and the FY2010 annual result was $26.9 million, up 11.62% from the prior year.
- Curent Deferred Tax Liability improved to $26.9 million in Q4 2010 per SYK's latest filing, from $24.1 million in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $26.9 million in Q4 2010 and troughed at $24.1 million in Q4 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 26.90 Mn |
| Dec 31, 2010 | 26.90 Mn |
| Dec 31, 2009 | 24.10 Mn |
| Dec 31, 2009 | 24.10 Mn |